JP2011514347A - フェノール酸を含むアブラヤシ葉からの抽出物 - Google Patents

フェノール酸を含むアブラヤシ葉からの抽出物 Download PDF

Info

Publication number
JP2011514347A
JP2011514347A JP2010549595A JP2010549595A JP2011514347A JP 2011514347 A JP2011514347 A JP 2011514347A JP 2010549595 A JP2010549595 A JP 2010549595A JP 2010549595 A JP2010549595 A JP 2010549595A JP 2011514347 A JP2011514347 A JP 2011514347A
Authority
JP
Japan
Prior art keywords
acid
extract
oil palm
composition according
catechin gallate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010549595A
Other languages
English (en)
Japanese (ja)
Inventor
リン ファング、ニー
ハーリド モハド．ファイルーブ ヤスミン アブドゥル
クアン リム、チャイ
アスマ ハムバリ、シティ
シャリフ、シャルハルフィザ
スライスンガム、サンゲーサ
Original Assignee
ノバ ラボラトリーズ エスディーエヌ ビーエイチディー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノバ ラボラトリーズ エスディーエヌ ビーエイチディー filed Critical ノバ ラボラトリーズ エスディーエヌ ビーエイチディー
Publication of JP2011514347A publication Critical patent/JP2011514347A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Botany (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medical Informatics (AREA)
JP2010549595A 2008-03-06 2009-02-12 フェノール酸を含むアブラヤシ葉からの抽出物 Pending JP2011514347A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MYPI20080538A MY157650A (en) 2008-03-06 2008-03-06 Extract from oil palm leaves comprising phenolic acids
PCT/MY2009/000028 WO2009110782A1 (fr) 2008-03-06 2009-02-12 Extrait de feuille de palmier à huile qui comprend des acides phénoliques

Publications (1)

Publication Number Publication Date
JP2011514347A true JP2011514347A (ja) 2011-05-06

Family

ID=41056226

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010549595A Pending JP2011514347A (ja) 2008-03-06 2009-02-12 フェノール酸を含むアブラヤシ葉からの抽出物

Country Status (8)

Country Link
EP (1) EP2262518A4 (fr)
JP (1) JP2011514347A (fr)
KR (1) KR20100136978A (fr)
CN (1) CN102123720B (fr)
AU (1) AU2009220290A1 (fr)
MY (1) MY157650A (fr)
TW (1) TW200940081A (fr)
WO (1) WO2009110782A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019131759A1 (fr) * 2017-12-27 2019-07-04 サントリーホールディングス株式会社 Composition améliorant une fonction de barrière intestinale

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110189222A1 (en) * 2008-09-30 2011-08-04 Suhaila Mohamed Composition for wound healing
MY161839A (en) 2009-05-18 2017-05-15 Malaysian Palm Oil Board A composition for use in the prevention and treatment of cardiovascular diseases
MY185582A (en) * 2010-01-07 2021-05-24 Malaysian Palm Oil Board Anti-obesity and anti-dyslipidemic effects of oil palm phenolics in preventing atheroslerosis and cardiovascular disease
CN102504706B (zh) * 2011-11-21 2013-07-10 陈永刚 稀土漆面护理液
TWI591335B (zh) 2011-12-29 2017-07-11 陶氏農業科學公司 利用鹼皂化作用來對植物組織樣本總油含量進行比色測定之技術
US11071313B2 (en) 2013-02-20 2021-07-27 Palm Silage, Inc. Palm-based animal feed
US11064717B2 (en) 2013-02-20 2021-07-20 Palm Silage, Inc. Palm-based animal feed
MY179462A (en) * 2013-10-11 2020-11-06 Malaysian Palm Oil Board Protective effects of oil palm composition on alzheimer?s disease
CN103642850A (zh) * 2013-12-10 2014-03-19 江南大学 一种阿魏酸体外抗氧化活性的测定方法
US20160278416A1 (en) * 2015-03-24 2016-09-29 Malaysian Palm Oil Board (Mpob) Methods for producing water soluble oil palm leaf powder and concentrate

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01175978A (ja) * 1987-12-29 1989-07-12 Itouen:Kk 粗カテキン化合物製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58144382A (ja) * 1982-02-19 1983-08-27 Agency Of Ind Science & Technol トコフエロ−ル及びトコトリエノ−ルの分離方法
JPS62108876A (ja) * 1985-11-07 1987-05-20 Mitsubishi Gas Chem Co Inc ビタミンｅの製造法
JPS6363754A (ja) * 1986-09-03 1988-03-22 Daiichi Eng Kk カロチンの分離方法
JPH02219890A (ja) * 1989-02-22 1990-09-03 Japan Tobacco Inc 抗酸化剤
JP2004203848A (ja) * 2002-12-20 2004-07-22 Lion Corp 植物抽出物含有組成物
WO2007129136A1 (fr) * 2006-05-08 2007-11-15 Achidi Valentin Agon Proprietes antipaludeennes des extraits des feuilles de elaeis guineensis (palmier a huile)
MY164863A (en) * 2007-07-11 2018-01-30 Univ Putra Malaysia Extract from palm leaves and a method for producing the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01175978A (ja) * 1987-12-29 1989-07-12 Itouen:Kk 粗カテキン化合物製造方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JPN6013031341; ＳＵＮ　ＲＵＮ-ＣＡＮＧ　ｅｔ　ａｌ: 'Ｑｕａｎｔｉｔａｔｉｖｅ　ｄｅｔｅｒｍｉｎａｔｉｏｎ　ｏｆ　ｈｙｄｒｏｘｙｃｉｎｎａｍｉｃ　ａｃｉｄｓ　ｉｎ　ｗｈｅａｔ，　ｒｉｃｅ，　ｒｙｅ，　ａｎｄ　ｂａｒｌｅｙ　ｓｔｒａｗｓ，　ｍａｉｚｅ　ｓｔ' Ｊｏｕｒｎａｌ　ｏｆ　Ａｇｒｉｃｕｌｔｕｒａｌ　ａｎｄ　Ｆｏｏｄ　Ｃｈｅｍｉｓｔｒｙ Ｖｏｌ．４９，Ｎｏ．１１, 2001, ｐｐ．５１２２-５１２９ *
JPN6013031344; ＡＢＥＹＷＡＲＤＥＮＡ　Ｍ　ＥＴ　ＡＬ: 'Ｐｏｌｙｐｈｅｎｏｌ-ｅｎｒｉｃｈｅｄ　ｅｘｔｒａｃｔ　ｏｆ　ｏｉｌ　ｐａｌｍ　ｆｒｏｎｄｓ　（Ｅｌａｅｉｓ　ｇｕｉｎｅｅｎｓｉｓ）　ｐｒｏｍｏｔｅｓ　ｖａｓｃｕｌａｒ　ｒｅｌａｘａｔｉｏｎ　ｖｉａ' ＡＳＩＡ　ＰＡＣＩＦＩＣ　ＪＯＵＲＮＡＬ　ＯＦ　ＣＬＩＮＩＣＡＬ　ＮＵＴＲＩＴＩＯＮ Ｖｏｌ．１１，Ｎｏ．Ｓｕｐｐｌ, 2002, Ｓ４６７　-　Ｓ４７２ *
JPN6013031347; Ｉｒｉｎｅ　Ｒ　ｅｔ　ａｌ: 'Ａｎｔｉｏｘｉｄａｎｔ　ａｎｄ　ｈｙｐｏｃｈｏｌｅｓｔｅｒｏｌｅｍｉｃ　ｅｆｆｅｃｔｓ　ｏｆ　Ｅｌａｅｉｓ　ｇｕｉｎｅｅｎｓｉｓ　ｆｒｏｎｄ　ｅｘｔｒａｃｔ　ｏｎ　ｈｙｐｅｒｃｈｏｌｅｓｔｅｒｏｌｅ' ＡＳＥＡＮ　Ｆｏｏｄ　Ｊｏｕｒｎａｌ Ｖｏｌ．１２, 2003, ｐｐ．１３７-１４７ *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019131759A1 (fr) * 2017-12-27 2019-07-04 サントリーホールディングス株式会社 Composition améliorant une fonction de barrière intestinale
CN111526735A (zh) * 2017-12-27 2020-08-11 三得利控股株式会社 肠道屏障功能改善用组合物
JPWO2019131759A1 (ja) * 2017-12-27 2020-12-24 サントリーホールディングス株式会社 腸管バリア機能改善用組成物
JP7252904B2 (ja) 2017-12-27 2023-04-05 サントリーホールディングス株式会社 腸管バリア機能改善用組成物

Also Published As

Publication number Publication date
MY157650A (en) 2016-07-15
TW200940081A (en) 2009-10-01
CN102123720A (zh) 2011-07-13
AU2009220290A1 (en) 2009-09-11
EP2262518A1 (fr) 2010-12-22
CN102123720B (zh) 2013-11-06
WO2009110782A1 (fr) 2009-09-11
KR20100136978A (ko) 2010-12-29
EP2262518A4 (fr) 2012-03-28

Similar Documents

Publication Publication Date Title
JP2011514347A (ja) フェノール酸を含むアブラヤシ葉からの抽出物
EP2331089B1 (fr) Utilisations de dérivés de sesquiterpène
US5762936A (en) Antioxidant derived from lentil and its preparation and uses
WO2010073404A1 (fr) Proanthocyanidine de pomme de cajou, composition contenant de la proanthocyanidine et utilisation de cette proanthocyanidine
JPH10506903A (ja) 抗新形成性のココア抽出物の製造および使用方法
CN102762573A (zh) 用于在神经退行性障碍中保护脑部健康的化合物、组合物和方法
EP0810222B1 (fr) Procédé d'extraction de polyphénols catéchiques à partir de potentilles, extrait obtenu et son utilisation
Okwu et al. Evaluation of the phytochemical composition of mango (Mangifera indica Linn) stem bark and leaves
US20060073220A1 (en) Cinnamon extract enriched for polyphenols and methods of preparing same
KR100486763B1 (ko) 항산화 활성이 있는 맹종죽엽 추출물 및 그 제조방법
JP5751981B2 (ja) 新規フェニルエタノイド配糖体及び皮膚化粧料
KR101384423B1 (ko) 자소엽 추출물을 포함하는 뇌신경질환 예방 또는 치료용 의약 조성물
KR20020010999A (ko) 항산화 활성이 있는 생열귀나무 추출물 및 이를 이용한플라반계 화합물의 제조방법
BR112021003813A2 (pt) antioxidantes botânicos
US20080193572A1 (en) Extracts of Ginkgo Biloba
US20110177178A1 (en) Extracts of Deschampsia antarctica Desv. with antineoplastic activity
WO2011038472A1 (fr) Extrait végétal normalisé, procédé de préparation d'extrait de plantes du genre sclerolobium, composition cosmétique, composition pharmaceutique et utilisation dudit extrait
KR100507989B1 (ko) 아실 코에이:디아실글리세롤 아실트랜스퍼라제 저해활성을 갖는 고삼 추출물 또는 프레닐플라보노이드화합물을 함유하는 조성물
JP7325149B1 (ja) 芳香族化合物配糖体及び該配糖体の製造方法、該配糖体を含む抗酸化組成物、脂質代謝改善組成物及び糖尿病改善・予防組成物
JP5591122B2 (ja) カシューアップルのプロアントシアニジン、プロアントシアニジン含有組成物、およびその用途
JP2004115472A (ja) 新規抗発癌プロモーター活性剤
Ribeiro Synthesis and Biological Evaluation of Olive Oil Polyphenol Metabolites
MANYAEM et al. THE ISOLATION OF BIOACTIVE COMPOUNDS FROM THE BRANCHES OF PLUMBAGO INDICA L.
Sharma A Comparative In-Vitro Study of Antioxidant Activity of Fresh and Dry Guduchi Tinospora Cordifolia (Willd) Miers. Stems
BR102021022111A2 (pt) Composição de microcápsulas de uncaria tomentosa, processos de obtenção e caracterização de microcápsulas de uncaria tomentosa e usos da mesma

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120123

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130628

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140502